Chemours (NYSE:CC) PT Lowered to $30.00

Chemours (NYSE:CC – Get Free Report) had its price target cut by equities research analysts at Barclays from $32.00 to $30.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective points to a potential upside of 4.42% from […]

Leave a Reply

Your email address will not be published.

Previous post Wells Fargo & Company Reaffirms “Overweight” Rating for Citigroup (NYSE:C)
Next post Imperial Oil Limited (NYSEAMERICAN:IMO) Sees Large Growth in Short Interest